1196-65-2 Usage
General Description
Benzaldehyde, 4-amino-2-methoxy- is an organic chemical compound with the molecular formula C8H9NO2. It is a derivative of benzaldehyde with an amino and methoxy group attached to the benzene ring. Benzaldehyde, 4-amino-2-methoxy- is commonly used in the production of pharmaceuticals and agrochemicals, and it also has potential applications in the field of organic synthesis. It is known for its almond-like odor and is often used as a flavoring agent in food products and as a fragrance ingredient in perfumes and cosmetics. Additionally, it is a versatile building block for the synthesis of various biologically active compounds. Overall, benzaldehyde, 4-amino-2-methoxy- is an important chemical with diverse industrial and commercial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1196-65-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,9 and 6 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1196-65:
(6*1)+(5*1)+(4*9)+(3*6)+(2*6)+(1*5)=82
82 % 10 = 2
So 1196-65-2 is a valid CAS Registry Number.
1196-65-2Relevant articles and documents
SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF
-
Paragraph 0889-0890, (2020/02/19)
This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a 6,5-heterocyclic structure (e.g., compounds having a imidazopyridine, imidazopyrimidine, imidazopyrazine, imidazopyridazine, imidazotriazine, benzoimidazole, benzotriazole, benzoisoxazole, purine, indazole, triazolotriazine, triazolopyridazine, triazolopyrimidine, triazolopyrazine, triazolotetrazine, triazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolopyridazine, pyrazolotriazine, pyrazolopyridine, isoxazolopyrazine, isoxazolopyrimidine, isoxazolopyrdiazine, isoxazolotriazine, or isoxalopyridine structure) which function as inhibitors of DYRK1A, DYRK1B, and Clk-1, and their use as therapeutics for the treatment of Alzheimer's disease, Down syndrome, diabetes, glioblastoma, autoimmune diseases, cancer (e.g., glioblastoma, prostate cancer), inflammatory disorders (e.g., airway inflammation), and other diseases.